Gastric Volume in Patients on GLP-1 Medications
Evaluating gastric volume in patients on GLP-1 RA medications
Conditions:
🦠 Diabetes
🗓️ Study Start (Actual) 6 June 2023
🗓️ Primary Completion (Estimated) 31 December 2024
✅ Study Completion (Estimated) 31 December 2024
👥 Enrollment (Estimated) 110
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Philadelphia, Pennsylvania, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • Fasting Diabetic On GLP-1 RA

    Exclusion Criteria:

    • Prior surgery that affects gastric anatomy
Ages Eligible for Study: N/A to 18 Years (CHILD, ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 6 June 2023
  • First Submitted that Met QC Criteria 6 June 2023
  • First Posted 15 June 2023

Study Record Updates

  • Last Update Submitted that Met QC Criteria 25 March 2024
  • Last Update Posted 27 March 2024
  • Last Verified March 2024